STOCK TITAN

Bristol Myers (BMYMP) Stock Price, News & Analysis

BMYMP OTC Link
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
7 52 sessions, September 9, 2025 to March 18, 2026
Largest daily move
-18.7% close of March 13, 2026
1-year change
-10.8% adjusted closes, September 9, 2025 to March 18, 2026

Company Description

BMYMP has declined 33.3% over the past year. Shares last traded at $700.00.

For FY2025, Bristol Myers reported revenue of $48.2B with net income of $7.1B and diluted earnings per share of $3.46. The company operates at a net profit margin of 14.6%.

This page collects what Stock Titan holds for BMYMP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-33.3%
Performance 1 year

Bristol Myers (BMYMP) last closed at $700.00. Over the past 12 months, BMYMP has lost 33.3%.

See what a $1,000 investment in BMYMP would be worth today

BMYMP Rankings

Latest News

No recent news available for BMYMP.

SEC Filings

Bristol Myers has filed 5 recent SEC filings, including 2 Form 4, 2 Form 8-K, 1 Form 10-Q. The most recent filing was submitted on June 5, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BMYMP SEC filings →

Financial Highlights

Bristol Myers generated $48.2B in revenue in FY2025, retaining a 71.1% gross margin, and net income was $7.1B, reflecting a 14.6% net profit margin. Diluted earnings per share stood at $3.46. The company generated $14.2B in operating cash flow. With a current ratio of 1.26, the company maintains adequate short-term liquidity.

$48.2B
Revenue (FY2025)
$7.1B
Net Income (FY2025)
$14.2B
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Bristol Myers (BMYMP) currently stands at 49 shares, representing 1.4% of the float. This relatively low short interest suggests limited bearish sentiment. With 49.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Bristol Myers (BMYMP) currently stands at 49.0 days, up 1799.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1172.7% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.

Frequently Asked Questions

What is the current quoted price of Bristol Myers (BMYMP)?

The current quoted price of Bristol Myers (BMYMP) is $700 as of March 18, 2026.

What is the revenue of Bristol Myers (BMYMP) stock?

The FY2025 revenue of Bristol Myers (BMYMP) is $48.2B, from its most recent completed fiscal year.

What is the net income of Bristol Myers (BMYMP)?

The FY2025 net income of Bristol Myers (BMYMP) is $7.1B, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Bristol Myers (BMYMP)?

The diluted earnings per share (EPS) of Bristol Myers (BMYMP) is $3.46 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Bristol Myers (BMYMP)?

The operating cash flow of Bristol Myers (BMYMP) is $14.2B. Learn about cash flow.

What is the profit margin of Bristol Myers (BMYMP)?

The net profit margin of Bristol Myers (BMYMP) is 14.6%. Learn about profit margins.

What is the gross margin of Bristol Myers (BMYMP)?

The gross profit margin of Bristol Myers (BMYMP) is 71.1%. Learn about gross margins.

What is the current ratio of Bristol Myers (BMYMP)?

The current ratio of Bristol Myers (BMYMP) is 1.26, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Bristol Myers (BMYMP)?

The gross profit of Bristol Myers (BMYMP) is $34.3B for FY2025, its most recent completed fiscal year.